To test this hypothesis, pep-20, a CD47/SIRPα interaction-blocking peptide (29), was employed for the treatment of the s.c. MC38 colon carcinoma model of C57BL/6 mice. The gene discussed is SIRPA; the disease is colon carcinoma.